NO20066005L - Injiserbar farmasoytisk suspensjon omfattende posaconazol - Google Patents

Injiserbar farmasoytisk suspensjon omfattende posaconazol

Info

Publication number
NO20066005L
NO20066005L NO20066005A NO20066005A NO20066005L NO 20066005 L NO20066005 L NO 20066005L NO 20066005 A NO20066005 A NO 20066005A NO 20066005 A NO20066005 A NO 20066005A NO 20066005 L NO20066005 L NO 20066005L
Authority
NO
Norway
Prior art keywords
posaconazole
injectable pharmaceutical
pharmaceutical suspension
configurations
suspension
Prior art date
Application number
NO20066005A
Other languages
English (en)
Inventor
Sydney Ugwu
Leonore Witchey-Lakshmanan
Varda Sandweiss
Catherine Hardalo
Roberta S Hare
Gopal Krishna
Zaiqi Wang
Marco Taglietti
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34971355&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20066005(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20066005L publication Critical patent/NO20066005L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer utforminger som er anvendbare for behandling av infeksjoner, nærmere bestemt utforminger som omfatter den aktive farmasøytiske bestanddel posakonazol i en injiserbar suspensjon som er stabil når den behandles ved avsluttende dampsterilisering. Fig. 4
NO20066005A 2004-05-28 2006-12-22 Injiserbar farmasoytisk suspensjon omfattende posaconazol NO20066005L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57512604P 2004-05-28 2004-05-28
PCT/US2005/018945 WO2005117831A1 (en) 2004-05-28 2005-05-27 Injectable pharmaceutical suspension comprising posaconazole

Publications (1)

Publication Number Publication Date
NO20066005L true NO20066005L (no) 2007-02-27

Family

ID=34971355

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20066005A NO20066005L (no) 2004-05-28 2006-12-22 Injiserbar farmasoytisk suspensjon omfattende posaconazol

Country Status (15)

Country Link
EP (1) EP1761247A1 (no)
JP (1) JP2008501034A (no)
KR (1) KR20070027564A (no)
CN (1) CN1988887A (no)
AR (1) AR049063A1 (no)
AU (1) AU2005249502A1 (no)
CA (1) CA2567803A1 (no)
IL (1) IL179627A0 (no)
MX (1) MXPA06013886A (no)
NO (1) NO20066005L (no)
PE (1) PE20060291A1 (no)
RU (1) RU2006146555A (no)
TW (1) TWI290051B (no)
WO (1) WO2005117831A1 (no)
ZA (1) ZA200609890B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060009469A1 (en) * 2004-05-28 2006-01-12 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmacutical compositions of posaconazole
RU2008148977A (ru) 2006-05-12 2010-06-20 Фармакон-Форшунг Унд Бератунг Гмбх (At) Применение комбинированных препаратов, содержащих противогрибковые средства
EP2130540A1 (en) 2008-06-02 2009-12-09 Sandoz AG Pharmaceutical compositions containing a crystalline form of posaconazole
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
EP2451805A1 (en) 2009-07-09 2012-05-16 Sandoz AG A crystalline form of posaconazole
US9199919B2 (en) 2010-05-19 2015-12-01 Sandoz Ag Process for the preparation of chiral hydrazides
US9206146B2 (en) 2010-05-19 2015-12-08 Sandoz Ag Purification of posaconazole and of posaconazole intermediates
EP2571871B1 (en) 2010-05-19 2017-06-21 Sandoz AG Process for the preparation of chiral triazolones
RU2580318C2 (ru) 2010-05-19 2016-04-10 Сандоз Аг Получение промежуточных продуктов для синтеза позаконазола
JP6008849B2 (ja) * 2010-06-29 2016-10-19 メルク・シャープ・エンド・ドーム・コーポレイション 置換β−シクロデキストリンにより安定化されたポサコナゾール静脈注射用溶液製剤
CN108329303A (zh) 2011-06-16 2018-07-27 桑多斯股份公司 制备手性化合物的方法
CN103284959B (zh) * 2012-02-22 2015-06-03 重庆圣华曦药业股份有限公司 泊沙康唑冻干粉针剂及制备方法
CN102755628B (zh) * 2012-07-16 2013-10-23 中国科学院微生物研究所 一种抗真菌的药物组合物
CN102805731B (zh) * 2012-08-22 2014-04-30 北京莱瑞森医药科技有限公司 泊沙康唑干混悬剂及其制备方法
CN105030668B (zh) * 2015-06-26 2018-03-27 济川药业集团有限公司 泊沙康唑口服混悬剂及其制备方法
CN106333925B (zh) * 2015-07-10 2019-06-18 上海美悦生物科技发展有限公司 一种泊沙康唑液体混悬剂及其制备方法
CN105997872B (zh) * 2016-07-08 2019-02-19 河南省立眼科医院 一种含有泊沙康唑的眼用纳米胶束抗真菌溶液
MX2019011603A (es) * 2017-03-26 2021-08-16 Robyn Vivi Stafford Metodo de tratamiento de las condiciones de la piel de los parpados.
CN111093373A (zh) * 2017-04-12 2020-05-01 V·J·班格万丁 组合物、包装的药物和使用泊沙康唑用于敏化抗性肿瘤的方法
CN110507609B (zh) * 2018-05-21 2021-09-17 上海医药工业研究院 泊沙康唑口服混悬剂的制备方法
CN111514146A (zh) * 2020-04-28 2020-08-11 山西振东泰盛制药有限公司 含有泊沙康唑的药物组合物
CN113933131B (zh) * 2021-09-24 2024-01-26 合肥天一生物技术研究所有限责任公司 一种阴道微生物荧光染色液

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091188A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
CA2443089C (en) * 2001-04-03 2011-11-01 Schering Corporation Antifungal suspension of micronized posaconazole

Also Published As

Publication number Publication date
AR049063A1 (es) 2006-06-21
EP1761247A1 (en) 2007-03-14
RU2006146555A (ru) 2008-07-20
IL179627A0 (en) 2007-05-15
KR20070027564A (ko) 2007-03-09
PE20060291A1 (es) 2006-04-14
ZA200609890B (en) 2008-09-25
AU2005249502A1 (en) 2005-12-15
JP2008501034A (ja) 2008-01-17
WO2005117831A1 (en) 2005-12-15
TW200609001A (en) 2006-03-16
MXPA06013886A (es) 2007-01-26
TWI290051B (en) 2007-11-21
CA2567803A1 (en) 2005-12-15
CN1988887A (zh) 2007-06-27

Similar Documents

Publication Publication Date Title
EA200800798A1 (ru) Фармацевтические композиции, предназначенные для лечения нарушений внутреннего уха
NO20080338L (no) Forbindelser for behandling av multilegemiddelresistente bakterielle infeksjoner
TW200609001A (en) Particulate-stabilized injectable pharmaceutical compositions of posaconasole
EP2494059A4 (en) USE OF METHYLSULFONYLMETHANE (MSM) TO MODULATE MICROBIAL ACTIVITY
NO20076675L (no) Aminopiperidinquinoliner og deres azaisosteriske analoger med antibakteriell aktivitet
UA89220C2 (ru) Способ лечения вич/спида путем приема без пищи или в условиях голодания твердого фармацевтического дозированного состава ингибитора вич-протеазы
UA109878C2 (uk) Похідні ізохінолінону, фармацевтична композиція на їх основі (варіанти) та спосіб лікування захворювань (варіанти)
TW200602093A (en) Sterilization/disinfection cycle control
ATE548034T1 (de) Pharmazeutische zusammensetzungen mit droxidopa
NO20082269L (no) Nye piperaziner som antimalariamidler
DE602006017261D1 (de) Behandlung von neovaskulären augenerkrankungen, wie z.b. maculadegeneration, angioiden streifen, uveitis und makulaödemen
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
BRPI0508540B8 (pt) composto, composição farmacêutica, e, uso de um composto
EP4537828A3 (en) Phospholipid compounds and uses thereof
NO20084749L (no) Organiske forbindelser og deres anvendelser
CL2007002671A1 (es) Compuestos derivados de octahidro-pirrolo[3,4-c]pirrol; composicion farmaceutica que la comprende; y uso del compuesto en el tratamiento del vih, sida o arc.
MX2008001917A (es) Mezclas insecticidas, sinergicas.
NO20074850L (no) Oftalmologiske sammensetninger og anvendelse derav
AR052955A1 (es) Producto de combinacion de o- desmetilvanlafaxina y bazedoxifeno y usos del mismo
DK1763339T3 (da) Orale antimikrobielle farmaceutiske præparater
MX2008008556A (es) Derivados de triterpenoquinonas y triterpenofenoles y su aplicacion para el tratamiento de tumores y enfermedades parasitarias.
CR9074A (es) Agente para la profilaxis o tratamiento del sindrome metabolico
HRP20080413T3 (en) Medicament for the treatment of fungal infections, particularly aspergillosis
PT1896416E (pt) Heterociclos substituídos, sua utilização como medicamentos e preparações farmacêuticas que os compreendem

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application